Login

Jan Anders Karlsson, CEO, Verona Pharma 00:00:00

Share On Facebook Share On Twitter

Verona Pharma can make real difference to COPD market believes CEO Karlsson

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Leslie Hill Discusses Fiscal Year 2022 Results and Strategic Expansion | Leslie Hill, CEO ,  Record Currency Management.
00:00:00
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Dr. Stephanie Grach, an Assistant Professor of Medicine, Mayo Clinic
00:10:00
Kootenay Silver Expands with New Silver Project in Mexico
00:10:00
Western Australian Manganese Developer Poised for High-Purity Market Entry
00:10:00
Revolutionizing Telecommunications with Alex West | Alex West, CEO, Swoop Holdings Ltd.
00:10:00
AI in Travel: Jane Sun on Transforming the Industry at Trip.com | Morgan Stanley
00:10:00
Academy Securities: Empowering Veterans with Industry Expertise
00:00:00
ExpreS2ion Biotechnologies | Company presentation by CEO Bent U. Frandsen - Bent U. Frandsen, Chief Executive Officer, ExpreS2ion Biotech Holding
00:10:00
Ivanhoe Electric: Revolutionizing Copper Exploration with Green Tech
00:00:00
Elias Papatheodorou, CEO of Genkyotex, tells us more about his relationship with the BioDiscovery team
00:10:00
Support B2B companies digitizing legacy industries|Geri Kirilova,Managing Partner,Laconia
00:10:00
Bannerman Energy: Positioned for Uranium Market Surge with Fully Permitted Itango Project

© 2026 Nehu